{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:51:50Z","timestamp":1791496310408,"version":"4.3.4"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2024ZD0533401"],"award-info":[{"award-number":["2024ZD0533401"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82402719"],"award-info":[{"award-number":["82402719"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2027,3]]},"DOI":"10.1016\/j.cca.2026.122861","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:04:01Z","timestamp":1790687041000},"page":"122861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Troponin T versus troponin I in immune checkpoint inhibitor-associated myocarditis: Complementary roles in screening and confirmation"],"prefix":"10.1016","volume":"594","author":[{"given":"Hanyan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cca.2026.122861_bb0005","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1161\/CIRCULATIONAHA.123.062405","article-title":"Cardiomuscular biomarkers in the diagnosis and prognostication of immune checkpoint inhibitor myocarditis","volume":"148","author":"Lehmann","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.cca.2026.122861_bb0010","article-title":"Current diagnosis and management of immune related adverse events (irAEs) induced by immune checkpoint inhibitor therapy","volume":"8","author":"Kumar","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.cca.2026.122861_bb0015","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/cvr\/cvz026","article-title":"Cardiovascular toxicities associated with immune checkpoint inhibitors","volume":"115","author":"Hu","year":"2019","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.cca.2026.122861_bb0020","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"40","author":"Thygesen","year":"2019","journal-title":"Eur. Heart J."},{"issue":"9","key":"10.1016\/j.cca.2026.122861_bb0025","first-page":"631","article-title":"Cardiac troponin T and I: back to basics","volume":"12","author":"Mingels","year":"2023","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"issue":"13","key":"10.1016\/j.cca.2026.122861_bb0030","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1134\/S0006297913130063","article-title":"Human cardiac troponin complex. Structure and functions","volume":"78","author":"Katrukha","year":"2013","journal-title":"Biochemistry (Mosc)."},{"issue":"5","key":"10.1016\/j.cca.2026.122861_bb0035","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1161\/01.RES.83.5.471","article-title":"Troponin and tropomyosin: proteins that switch on and tune in the activity of cardiac myofilaments","volume":"83","author":"Solaro","year":"1998","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.cca.2026.122861_bb0040","first-page":"969","article-title":"Troponin: structure, properties, and mechanism of functioning","volume":"64","author":"Filatov","year":"1999","journal-title":"Biochemistry (Mosc.)"},{"issue":"3","key":"10.1016\/j.cca.2026.122861_bb0045","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1515\/cclm-2022-0778","article-title":"Differences between high-sensitivity cardiac troponin T and I in stable populations: underlying causes and clinical implications","volume":"61","author":"Eggers","year":"2023","journal-title":"Clin. Chem. Lab. Med."},{"issue":"41","key":"10.1016\/j.cca.2026.122861_bb0050","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the international cardio-oncology society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur. Heart J."},{"issue":"02","key":"10.1016\/j.cca.2026.122861_bb0055","first-page":"368","article-title":"Clinical recommendations for the diagnosis and management of immune checkpoint inhibitor-associated myocarditis [in Chinese]","volume":"30","author":"Wang","year":"2023","journal-title":"Zhongguo Linchuang Yixue."},{"issue":"4","key":"10.1016\/j.cca.2026.122861_bb0060","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/eurheartj\/ehab674","article-title":"Defining cardiovascular toxicities of cancer therapies: an international cardio-oncology society (IC-OS) consensus statement","volume":"43","author":"Herrmann","year":"2022","journal-title":"Eur. Heart J."},{"issue":"36","key":"10.1016\/j.cca.2026.122861_bb0065","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1200\/JCO.21.01440","article-title":"Management of Immune-Related Adverse Events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update","volume":"39","author":"Schneider","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.cca.2026.122861_bb0070","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jacc.2025.10.018","volume":"87","author":"Ganatra","year":"2026","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.cca.2026.122861_bb0075","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1001\/jamaoncol.2025.4543","article-title":"Immune checkpoint inhibitor-associated cardiovascular toxic effects: international cardio-oncology society position statement","volume":"12","author":"Herrmann","year":"2026","journal-title":"JAMA Oncol."},{"issue":"9","key":"10.1016\/j.cca.2026.122861_bb0080","article-title":"Case report of elevation of high-sensitivity cardiac troponin T in the absence of cardiac involvement in immune checkpoint inhibitor-associated myositis","volume":"6","author":"Ruperti-Repilado","year":"2022","journal-title":"Eur. Heart J. Case Rep."},{"issue":"12","key":"10.1016\/j.cca.2026.122861_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.101375","article-title":"Elevations of cardiac troponin in patients receiving immune checkpoint inhibitors: data from a prospective study","volume":"3","author":"van den Berg","year":"2024","journal-title":"JACC Adv."},{"key":"10.1016\/j.cca.2026.122861_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.115186","article-title":"Optimized monitoring for immune checkpoint inhibitor induced myocarditis using high-sensitivity troponin-T","volume":"216","author":"Tomsitz","year":"2025","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"10.1016\/j.cca.2026.122861_bb0095","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13400","article-title":"Pre-treatment high-sensitivity troponin T for the short-term prediction of cardiac outcomes in patients on immune checkpoint inhibitors","volume":"51","author":"Petricciuolo","year":"2021","journal-title":"Eur. J. Clin. Invest."},{"issue":"16","key":"10.1016\/j.cca.2026.122861_bb0100","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.jacc.2018.02.037","article-title":"Myocarditis in patients treated with immune checkpoint inhibitors","volume":"71","author":"Mahmood","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"12","key":"10.1016\/j.cca.2026.122861_bb0105","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S1470-2045(18)30608-9","article-title":"Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study","volume":"19","author":"Salem","year":"2018","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.cca.2026.122861_bb0110","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.advms.2018.08.016","article-title":"Cardiac troponins in chronic kidney disease patients with special emphasis on their importance in acute coronary syndrome","volume":"64","author":"Szczykowska","year":"2019","journal-title":"Adv. Med. Sci."},{"issue":"15","key":"10.1016\/j.cca.2026.122861_bb0115","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1161\/CIRCULATIONAHA.123.066565","article-title":"Half-life and clearance of cardiac troponin I and troponin T in humans","volume":"150","author":"Kristensen","year":"2024","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.cca.2026.122861_bb0120","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1002\/ehf2.14360","article-title":"Value of troponin T versus I in the diagnosis of immune checkpoint inhibitor-related myocarditis and myositis: rechallenge?","volume":"10","author":"Rossi","year":"2023","journal-title":"ESC Heart Fail."},{"issue":"1","key":"10.1016\/j.cca.2026.122861_bb0125","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jaccao.2021.01.004","article-title":"Myocarditis surveillance with high-sensitivity troponin I during Cancer treatment with immune checkpoint inhibitors","volume":"3","author":"Waliany","year":"2021","journal-title":"JACC CardioOncol."},{"issue":"20","key":"10.1016\/j.cca.2026.122861_bb0130","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.jacc.2023.03.403","article-title":"Myocardial injury thresholds for 4 high-sensitivity troponin assays in U.S. adults","volume":"81","author":"McEvoy","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.cca.2026.122861_bb0135","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/clinchem\/hvz032","article-title":"Discrepancy between cardiac troponin assays due to endogenous antibodies","volume":"66","author":"Lam","year":"2020","journal-title":"Clin. Chem."},{"issue":"2","key":"10.1016\/j.cca.2026.122861_bb0140","article-title":"Interfering heterophile antibodies as the cause of persistently falsely elevated high-sensitivity troponin I on Alinity i: a case report","volume":"35","author":"Lapi\u0107","year":"2025","journal-title":"Biochem Med (Zagreb)."},{"issue":"19","key":"10.1016\/j.cca.2026.122861_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics15192452","article-title":"99th-percentile upper reference limit for the new Snibe high-sensitivity troponin I assay in a southeast Asian population","volume":"15","author":"Zhang","year":"2025","journal-title":"Diagnostics"},{"issue":"7","key":"10.1016\/j.cca.2026.122861_bb0150","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1080\/10408347.2022.2144995","article-title":"Development of lateral flow assays for rapid detection of troponin I: a review","volume":"54","author":"Mohammadinejad","year":"2024","journal-title":"Crit. Rev. Anal. Chem."},{"issue":"1","key":"10.1016\/j.cca.2026.122861_bb0155","doi-asserted-by":"crossref","DOI":"10.2174\/1573403X18666220610164946","article-title":"Diagnostic role and methods of detection of cardiac troponins: an opinion from historical and current points of view","volume":"19","author":"Michailovich Chaulin","year":"2023","journal-title":"Curr. Cardiol. Rev."},{"key":"10.1016\/j.cca.2026.122861_bb0160","series-title":"High-sensitivity cardiac troponin I and T assay analytical characteristics designated by manufacturer","author":"IFCC Committee on clinical applications of cardiac bio-markers","year":"2026"},{"key":"10.1016\/j.cca.2026.122861_bb0165","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.clinbiochem.2020.02.005","article-title":"Evaluation of the new Beckman coulter access hsTnI: 99th percentile upper reference limits according to age and sex in the Korean population","volume":"79","author":"Kim","year":"2020","journal-title":"Clin. Biochem."},{"issue":"4","key":"10.1016\/j.cca.2026.122861_bb0170","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/CJI.0000000000000356","article-title":"Cardiac troponin I and T in checkpoint inhibitor-associated myositis and myocarditis","volume":"44","author":"Ang","year":"2021","journal-title":"J. Immunother."},{"issue":"2","key":"10.1016\/j.cca.2026.122861_bb0175","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001887","article-title":"Intensified immunosuppressive therapy in patients with immune checkpoint inhibitor-induced myocarditis","volume":"8","author":"Cautela","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.cca.2026.122861_bb0180","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-40073-8","article-title":"Opposing gene regulatory programs governing myofiber development and maturation revealed at single nucleus resolution","volume":"14","author":"Dos Santos","year":"2023","journal-title":"Nat. Commun."},{"issue":"24","key":"10.1016\/j.cca.2026.122861_bb0185","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1161\/CIRCULATIONAHA.121.058489","article-title":"Skeletal muscle disorders: a noncardiac source of cardiac troponin T","volume":"145","author":"du Fay de Lavallaz","year":"2022","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.cca.2026.122861_bb0190","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1515\/cclm-2021-0626","article-title":"Identification of macrotroponin T: findings from a case report and non-reproducible troponin T results","volume":"59","author":"Lam","year":"2021","journal-title":"Clin. Chem. Lab. Med."},{"issue":"8","key":"10.1016\/j.cca.2026.122861_bb0195","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1515\/cclm-2023-0028","article-title":"Antibody-mediated interferences affecting cardiac troponin assays: recommendations from the IFCC committee on clinical applications of cardiac biomarkers","volume":"61","author":"Hammarsten","year":"2023","journal-title":"Clin. Chem. Lab. Med."},{"issue":"Supplement_1","key":"10.1016\/j.cca.2026.122861_bb0200","article-title":"Troponin T elevation in the context of immune checkpoint inhibitor myositis: a case of macrotroponin-T and mistaken steroid-refractory myocarditis","volume":"9","author":"MacFadyen","year":"2025","journal-title":"Rheumatol. Adv. Pract."},{"issue":"9","key":"10.1016\/j.cca.2026.122861_bb0205","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000037280","article-title":"Troponin efficacy in the diagnosis of acute coronary syndrome in patients with chronic renal failure","volume":"103","author":"Ermete G\u00fcler","year":"2024","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.cca.2026.122861_bb0210","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2014-000108","article-title":"Cardiac troponin I but not cardiac troponin T adheres to polysulfone dialyser membranes in an in vitro haemodialysis model: explanation for lower serum cTnI concentrations following dialysis","volume":"1","author":"Gaze","year":"2014","journal-title":"Open Heart"},{"issue":"2","key":"10.1016\/j.cca.2026.122861_bb0215","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1681\/ASN.2017030341","article-title":"Renal dysfunction influences the diagnostic and prognostic performance of high-sensitivity cardiac troponin I","volume":"29","author":"Gunsolus","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.cca.2026.122861_bb0220","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/CRD.0000000000000461","article-title":"Utility of cardiac troponins in patients with chronic kidney disease","volume":"32","author":"Hti Lar Seng","year":"2024","journal-title":"Cardiol. Rev."},{"issue":"6","key":"10.1016\/j.cca.2026.122861_bb0225","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1159\/000510619","article-title":"Cardiac troponin is elevated in patients with thyrotoxicosis and decreases as thyroid function improves and brain natriuretic peptide levels decrease","volume":"10","author":"Watanabe","year":"2021","journal-title":"Eur Thyroid J."},{"issue":"5","key":"10.1016\/j.cca.2026.122861_bb0230","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/CJI.0000000000000555","article-title":"Effects of immune checkpoint inhibitor-induced thyroid dysfunction on cardiac troponin levels","volume":"48","author":"Shibutani","year":"2025","journal-title":"J. Immunother."},{"issue":"10","key":"10.1016\/j.cca.2026.122861_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109753","article-title":"Hypothyroidism and its rapid correction alter cardiac remodeling","volume":"9","author":"Hajje","year":"2014","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.cca.2026.122861_bb0240","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.jaccao.2024.07.001","article-title":"Cardiac troponin I and T in ICI myocarditis screening, diagnosis, and prognosis","volume":"6","author":"Barac","year":"2024","journal-title":"JACC CardioOncol."},{"issue":"4","key":"10.1016\/j.cca.2026.122861_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100216","article-title":"Clinical implications of isolated troponinemia following immune checkpoint inhibitor therapy","volume":"6","author":"Delombaerde","year":"2021","journal-title":"ESMO Open"},{"issue":"11","key":"10.1016\/j.cca.2026.122861_bb0250","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/jamacardio.2021.2241","article-title":"Clinical strategy for the diagnosis and treatment of immune checkpoint inhibitor-associated myocarditis: a narrative review","volume":"6","author":"Lehmann","year":"2021","journal-title":"JAMA Cardiol."},{"issue":"1","key":"10.1016\/j.cca.2026.122861_bb0255","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1515\/cclm-2022-0471","article-title":"Quantitation of cardiac troponin I in cancer patients treated with immune checkpoint inhibitors: a case-control study","volume":"61","author":"Ulndreaj","year":"2023","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2026.122861_bb0260","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1350585","article-title":"Circulating biomarkers in the diagnosis and prognosis of immune checkpoint inhibitor-related myocarditis: time for a risk-based approach","volume":"11","author":"Murtagh","year":"2024","journal-title":"Front. Cardiovasc. Med."},{"issue":"5","key":"10.1016\/j.cca.2026.122861_bb0265","doi-asserted-by":"crossref","first-page":"634","DOI":"10.21873\/cdp.10479","article-title":"Asymptomatic troponin elevation and early mortality following immune checkpoint inhibitor therapy in patients without cardiac adverse events","volume":"5","author":"Shibutani","year":"2025","journal-title":"Cancer Diagn Progn."},{"issue":"5","key":"10.1016\/j.cca.2026.122861_bb0270","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1002\/ehf2.13515","article-title":"High-sensitivity cardiac troponin T determines all-cause mortality in cancer patients: a single-Centre cohort study","volume":"8","author":"Finke","year":"2021","journal-title":"ESC Heart Fail."},{"issue":"10","key":"10.1016\/j.cca.2026.122861_bb0275","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.7233","article-title":"Cardiovascular adverse events associated with immune checkpoint inhibitors: a retrospective multicenter cohort study","volume":"13","author":"Zheng","year":"2024","journal-title":"Cancer Med."},{"issue":"6","key":"10.1016\/j.cca.2026.122861_bb0280","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyaf147","article-title":"The predictive value of serial troponin measurements in patients treated with immune checkpoint inhibitors","volume":"30","author":"Gvili Perelman","year":"2025","journal-title":"Oncologist"},{"issue":"6","key":"10.1016\/j.cca.2026.122861_bb0285","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.125.041680","article-title":"Diagnostic and prognostic value of high-sensitivity troponin T for cardiovascular outcomes in patients receiving immune checkpoint inhibitor therapy","volume":"15","author":"Pereyra Pietri","year":"2026","journal-title":"J. Am. Heart Assoc."},{"issue":"10","key":"10.1016\/j.cca.2026.122861_bb0290","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyaf285","article-title":"Immune checkpoint inhibitor-related myocarditis: a comprehensive analysis of clinical manifestations and prognostic factors","volume":"30","author":"Fan","year":"2025","journal-title":"Oncologist"},{"issue":"9","key":"10.1016\/j.cca.2026.122861_bb0295","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1093\/eurheartj\/ehaf315","article-title":"Immune checkpoint inhibitor-associated myocarditis: a novel risk score","volume":"47","author":"Power","year":"2026","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.cca.2026.122861_bb0300","article-title":"Peripheral blood cells and immune checkpoint inhibitor-associated myocarditis: a retrospective clinical study with pharmacovigilance and single-cell analysis","volume":"17","author":"Li","year":"2026","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.cca.2026.122861_bb0305","doi-asserted-by":"crossref","DOI":"10.36660\/abc.20250047i","article-title":"Prognostic value of troponin to lymphocyte ratio in patients with immune checkpoint inhibitor-associated myocarditis","volume":"122","author":"Chen","year":"2025","journal-title":"Arq. Bras. Cardiol."},{"issue":"5","key":"10.1016\/j.cca.2026.122861_bb0310","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00432-024-05801-7","article-title":"Nomograms based on ratio indexes to predict severity and prognosis in immune checkpoint inhibitors-related myocarditis: a retrospective analysis","volume":"150","author":"Li","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126020437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126020437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:45:34Z","timestamp":1791495934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126020437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,3]]},"references-count":62,"alternative-id":["S0009898126020437"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.122861","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2027,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Troponin T versus troponin I in immune checkpoint inhibitor-associated myocarditis: Complementary roles in screening and confirmation","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.122861","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"122861"}}